+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Spinal Cord Stimulation Market (2021-2026) by Product, Disease, End User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5503487
  • Report
  • November 2021
  • Region: Global
  • 165 Pages
  • Infogence Global Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Gimer Medical
  • LivaNova PLC
  • Neuronano
  • NeuroSigma, Inc.
  • Saluda Medical Pvt ltd
The Global Spinal Cord Stimulation Market is estimated to be USD 2.1 Bn in 2021 and is expected to reach USD 3.2 Bn by 2026, growing at a CAGR of 8.9%.



Market Dynamics

A spinal Cord Stimulator (SCS) device is surgically placed under your skin and sends a mild electric current to your spinal cord. Thin wires carry current from a pulse generator to the nerve fibres of the spinal cord. When turned on, the SCS stimulates the nerves in the area where your pain is felt. Factors such as increasing incidence of the failed back syndrome, availability of medical reimbursements, increase in the number of patients suffering from chronic pain and increasing incidence of complex regional pain syndrome are drivers for the market. Whereas adverse risks associated with spinal cord stimulation devices are restraints for the market growth.

Growing awareness in developing countries provides an opportunity for the market’s growth through the availability of therapies poses a challenge.

Market Segmentation


The Global Spinal Cord Stimulation Market is segmented further based on Product, Disease, End User and Geography.

By Product, the market is classified into Rechargeable and Non-Rechargeable segments.

By Disease, the market is classified into Failed Back Surgery Syndrome (FBSS), Degenerative Disc Disease (DDD), Complex Regional Pain Syndrome (CRPS), Arachnoiditis, Ischemic Limb Pain, and Others. Amongst all, the Failed back surgery syndrome (FBSS) segment is expected to contribute the highest growth.

By End User, the market is classified into Hospitals, Ambulatory Surgical Units, Speciality Clinics segments. Amongst all segments, the Hospitals segment is expected to grow at the highest CAGR.

By Geography, North America is projected to lead the market.

Recent Developments

1. Medtronic receives approval for US labelling of the Intellis platform showing superior back pain relief when using DTM spinal cord stimulation - 17th March 2021
2. Nervo announced that it has agreed to dismiss its patent case against Boston Scientific relating to high-frequency spinal cord stimulation therapy - 15th December 2020

Company Profiles

Some of the companies covered in this report are Abbott Laboratories, Autonomic Technologies Inc., Beijing PINS Medical Co., Ltd, BioControl Medical (B.C.M) Ltd., Bioinduction, Bluewind Medical, Boston Scientific Corporation, Cirtec Medical Corporation, and Gimer Medical, etc.

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Spinal Cord Stimulation Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Spinal Cord Stimulation Market

What is the estimated value of the Global Spinal Cord Stimulation Market?

The Global Spinal Cord Stimulation Market was estimated to be valued at $2100.0 Million in 2021.

What is the growth rate of the Global Spinal Cord Stimulation Market?

The growth rate of the Global Spinal Cord Stimulation Market is 8.8%, with an estimated value of $3200.0 Million by 2026.

What is the forecasted size of the Global Spinal Cord Stimulation Market?

The Global Spinal Cord Stimulation Market is estimated to be worth $3200.0 Million by 2026.

Who are the key companies in the Global Spinal Cord Stimulation Market?

Key companies in the Global Spinal Cord Stimulation Market include Abbott Laboratories, Autonomic Technologies Inc., Beijing PINS Medical Co., Ltd, BioControl Medical (B.C.M) Ltd., Bioinduction, Bluewind Medical, Boston Scientific Corporation, Cirtec Medical Corporation and Greatbatch, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Gimer Medical
  • LivaNova PLC
  • Neuronano
  • NeuroSigma, Inc.
  • Saluda Medical Pvt ltd

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Incidence of Failed Back Syndrome
4.1.2 Availability of Medical Reimbursements
4.1.3 Increase in Number of Patients Suffering from Chronic Pain
4.1.4 Increasing Incidence of Complex Regional Pain Syndrome
4.2 Restraints
4.2.1 Adverse Risks Associated with Spinal Cord Stimulation Devices
4.3 Opportunities
4.3.1 Growing Awareness in Developing Countries
4.4 Challenges
4.4.1 Availability of Therapies
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Spinal Cord Stimulation Market, By Product
6.1 Introduction
6.2 Rechargeable
6.3 Non-Rechargeable
7 Global Spinal Cord Stimulation Market, By Disease
7.1 Introduction
7.2 Failed Back Surgery Syndrome (FBSS)
7.3 Degenerative Disc Disease (DDD)
7.4 Complex Regional Pain Syndrome (CRPS)
7.5 Arachnoiditis
7.6 Ischemic Limb Pain
7.7 Others
8 Global Spinal Cord Stimulation Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Units
8.4 Speciality Clinics
9 Global Spinal Cord Stimulation Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.3.3 Chile
9.3.4 Colombia
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Spain
9.4.6 Netherlands
9.4.7 Sweden
9.4.8 Russia
9.4.9 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Indonesia
9.5.5 Malaysia
9.5.6 South Korea
9.5.7 Australia
9.5.8 Sri Lanka
9.5.9 Thailand
9.5.10 Rest of APAC
9.6 Middle-East and Africa
9.6.1 Qatar
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 United Arab Emirates
10 Competitive Landscape
10.1 IGR Competitive Quadrant
10.2 Market Share Analysis
10.3 Strategic Initiatives
10.3.1 M&A and Investments
10.3.2 Partnerships and Collaborations
10.3.3 Product Developments and Improvements
11 Company Profiles
11.1 Abbott Laboratories
11.2 Autonomic Technologies Inc.
11.3 Beijing PINS Medical Co., Ltd
11.4 BioControl Medical (B.C.M) Ltd.
11.5 Bioinduction
11.6 Bluewind Medical
11.7 Boston Scientific Corporation
11.8 Cirtec Medical Corporation
11.9 Gimer Medical
11.10 Greatbatch, Inc.
11.11 GTX Medical
11.12 Helius Medical Technologies
11.13 Integer Holdings Corporation
11.14 LivaNova PLC
11.15 Medtronic PLC
11.16 Microtransponder
11.17 Neuronano
11.18 Neuronetics Inc.
11.19 Neuropace Inc.
11.20 NeuroSigma, Inc.
11.21 Nevro Corp.
11.22 Nuvectra
11.23 Saluda Medical Pvt ltd
11.24 Soterix Medical
11.25 Spinal Modulation
11.26 Stimwave LLC
11.27 Synapse Biomedical, Inc.
12 Appendix
12.1 Questionnaire
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Autonomic Technologies Inc.
  • Beijing PINS Medical Co., Ltd
  • BioControl Medical (B.C.M) Ltd.
  • Bioinduction
  • Bluewind Medical
  • Boston Scientific Corporation
  • Cirtec Medical Corporation
  • Gimer Medical
  • Greatbatch, Inc.
  • GTX Medical
  • Helius Medical Technologies
  • Integer Holdings Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Microtransponder
  • Neuronano
  • Neuronetics Inc.
  • Neuropace Inc.
  • NeuroSigma, Inc.
  • Nevro Corp.
  • Nuvectra
  • Saluda Medical Pvt ltd
  • Soterix Medical
  • Spinal Modulation
  • Stimwave LLC
  • Synapse Biomedical, Inc.
Note: Product cover images may vary from those shown